Travere Therapeutics (TVTX) PT Raised to $46 at Wedbush, Following Clinical Update

February 2, 2021 1:59 PM EST
Get Alerts TVTX Hot Sheet
Price: $24.52 -4.26%

Rating Summary:
    1 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 19 | Down: 18 | New: 47
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst Laura Chico raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $46.00 (from $38.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change